Are you a distributor of molecular biology reagents? Meet DIANA Biotechnologies.

DIANA Biotechnologies, a Czech biotech company, is looking for distributor partners at Lab Innovations, NEC Birmingham, 4-5 November 2026.

Their team of molecular biology, chemistry, pharmacology and automation specialists develops and manufactures high-performance reagents for research labs and life science partners:
🧬 Engineered PCR and RT-PCR mixes
🔬 RNase inhibitors and reverse transcriptases
⚗️ Highly engineered enzymes for demanding nucleic acid workflows

They also offer custom oligonucleotide synthesis, kinase inhibitor profiling, monoclonal antibody development and drug discovery services, and develop diagnostic solutions, including ultrasensitive sepsis diagnostics.

They’re looking for distributors across Europe, Eastern/Central Europe, the Middle East, Africa, Asia Pacific, North America and South America.

Introduce your company to DIANA Biotechnologies:
👉 Online, via the BCP Partnering Portal: https://db.biochannelpartners.com/premium/182945
👉 In person, at the Meet the Distributor networking event during Lab Innovations: https://www.lab-innovations.com/meet-the-distributor/

Whether you want to strengthen your current portfolio or add complementary technologies, DIANA Biotechnologies would be delighted to explore how you could work together.

#LabInnovations #MeetTheDistributor #DistributorSearch #ChannelDevelopment #MolecularBiology #PCR #LifeSciences #BioChannelPartners #BCPPartneringPortal #DIANABiotechnologies

DIANA Biotechnologies is a biotech company that provides innovative solutions across the biotech sector, including diagnostic and academic labs, monoclonal antibody development, and drug discovery services. The company's core business involves the development and production of PCR and RT-PCR products, custom oligonucleotide synthesis, and comprehensive kinase inhibitor profiling services. They also offer a range of products, including ultrasensitive sepsis diagnostics, RNase inhibitors, and reverse transcriptase. Additionally, the company provides services such as monoclonal antibody development and drug discovery, leveraging their expertise in medical and organic chemistry, biochemistry, and pharmacology to drive healthcare advancements.

DIANA Biotechnologies is a Czech biotech company that advances research and development. Powered by a team of top scientists in molecular biology, chemistry, pharmacology, and automation, we provide R&D services and products for academic labs, biotech companies, and pharmaceutical partners. Our offerings include the development of engineered PCR reagents, monoclonal antibodies and drug discovery services.

DIANA Biotechnologies is a biotechnology company focused on the development and production of high-performance reagents for molecular biology and life science research. Its portfolio includes advanced PCR and RT-PCR mixes, RNase inhibitors, reverse transcriptases, and highly engineered enzymes, designed to provide high sensitivity, robustness, and reliable performance across demanding research applications.
Building on strong expertise in protein engineering, biochemistry, molecular biology, and organic chemistry, DIANA develops both individual enzymes and optimized reagent systems for PCR, RT-PCR, and other nucleic acid workflows. The company combines in-house R&D with manufacturing capabilities, enabling it to translate enzyme engineering into practical products for research laboratories and life science partners.
Beyond its core molecular biology reagent portfolio, DIANA Biotechnologies also offers custom oligonucleotide synthesis, kinase inhibitor profiling, monoclonal antibody development, and drug discovery services, as well as developing innovative diagnostic solutions.